Research and Markets(http://www.researchandmarkets.com/research/0249be/global_drug_elutin) has announced the addition of the "Global Drug Eluting (DES), Bare Metal (BMS) and Other Coronary Stents Market (2011 - 2016)" report to their offering.
The coronary stents market has witnessed patterns of increasing market growth along with some declining phases in its course of span. The introduction of drug-eluting stents (DES) in year 2000 marked a high market growth phase of the market. In the early 2000, the coronary stent market witnessed a spurt in growth. However, the year 2006 and 2007 experienced a steep decline in the market revenues, as a result of release of some adverse clinical trials raising questions about safety and efficacy of DES. The market again started regaining its growth phase by 2008 with improvements in its stability. Prior to the introduction of drug-eluting stents (DES), Bare metal stents (BMS) captured the largest market share of Coronary Stent market worldwide. However, as a result of high penetration rates of DES now, its market share is the highest contributor to the market.
The global stent market in alignment to the high prevalence of cardiovascular diseases is gaining in its market share year after year. Also, owing the growth in demand for minimally invasive procedures, these stents especially drug-eluting stents are finding rapid increase in their market penetration of more than 60% approximately. Increase in the elderly population, lifestyle changes leading to Obesity and advent of advanced technologies such as bio absorbable and new generation stents are few major driving factors for the Global coronary stent market. Among the various market across the geographies, U.S forms the largest market for the Coronary stents followed by Europe, Asia-Pacific region countries, Japan and China. The leading players in this market include Johnson & Johnson, Boston Scientific, Abbott Laboratories and Medtronics forming the major share of the market worldwide.
The report covers all the major types of coronary stents - i.e. Drug Eluting Stents, Bare Metal Stents and Bio-Absorbable Stents. The report discusses the key influencing factors for the coronary stent market across the geographies. The report also includes an in-depth analysis of different sub-segments. The report estimates, forecasts the market sizes (2010-2016) and growth rates for different segments and geographies.
The report analysis the global trend of coronary stent market and discusses the rationale behind various industry moves. The report provides competitive scenario of this market and highlights major market going-on. An in-depth geographic analysis is conducted for each of the sub-segment in the major regional markets of Americas, Europe, Asia and ROW.
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Understanding Of The Market
Chapter 3 Market Overview
Chapter 4 Market Segmentation
Chapter 5 Competitive Landscape
Chapter 6 Trend Analysis
Chapter 7 Clinical Trials
Chapter 8 Company Profiles
For more information visit http://www.researchandmarkets.com/research/0249be/global_drug_elutinBusiness Wire
Last updated on: 03/02/2012
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.